{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
fludarabine phosphate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(1997)
Source URL:
First approved in 1997
Source:
21 CFR 333E
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA065488
(1991)
Source URL:
First approved in 1989
Source:
21 CFR 343
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT04026438: Phase 4 Interventional Completed Complication, Postoperative
(2019)
Source URL:
First approved in 1983
Source:
NADA125961
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Class:
MIXTURE
Status:
US Approved Rx
(2023)
Source:
BLA761204
(2023)
Source URL:
First approved in 2023
Source:
BLA761204
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2021)
Source:
BLA761194
(2021)
Source URL:
First approved in 2021
Source:
BLA761194
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761047
(2017)
Source URL:
First approved in 2017
Source:
BLA761047
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2015)
Source:
BLA125513
(2015)
Source URL:
First approved in 2015
Source:
BLA125513
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
